• Home
• Members
• Products
• Manufacturers
• Export / Import
• Indiabizclub
• Register Free

Search Members DirectoryProduct CatalogsSite Content

Directory

Company Profile

PANACEA BIOTEC LTD.

Ernakulam(kochi), Kerala, India

Pharmaceuticals Products - Manufacturer, Export / Import,
Public. Ltd. Firm Since 1989

The role of a health management company is highly crucial in a developing country like India having a huge population of over 1000 million. On one hand morbidity and mortality is much higher; on the other hand per capita expenditure is far less than many developed countries of the world. Global companies have been dominating the Indian pharmaceutical and health industry since its independence in 1947 for over 5 decades. However, in the last 2 decades, Indian companies have made a significant progress in providing much needed health solutions to the people of India. Their significant role is being recognized in various international markets as well. Though product quality is quintessential, especially in health products- affordability by the masses is also a crucial factor that would support the cause of a healthy living. Panacea Biotec has emerged as a leading health management company of India addressing both areas of concern.

From trading of pharmaceutical products to manufacturing, the journey for
Panacea Biotec had been adventurous and full of significant achievements. A medicine shop in Sialkot (a city in Pakistan) in 1927, is now what is known as Panacea Biotec that enjoys a prestigious 43rd rank amongst pharmaceutical companies of India in Retail Sales Audit (as per ORG Jul' 04) and 41st in Prescription Audit (as per CMARC Jul.' 04 - Oct.? 04). Both ORG and CMARC are leading independent market research companies of India.

Panacea Biotec manufactures and markets branded vaccines, pharmaceutical and biotechnology-based products of international quality. The manufacturing plant for Vaccines in the capital of India, New Delhi is prequalified by WHO for supply to U.N. Agencies. Panacea Biotec meets most of the state requirements of OPV under Pulse Polio Program in India. The plant for manufacture of pharmaceutical formulations got commissioned in 1989 in New Delhi. It is equipped with latest and most modern machinery, equipments and infrastructure to roll out products as per company?s stringent Quality Policy. The big thrust came in 1993, with focus on biological and biotechnology based products, in addition to pharmaceutical formulations.

The year 1995 saw the merger of its vaccines and pharmaceutical operations into one conglomerate named Panacea Biotec.It has since then been pursuing its mission - In Support Of Life - more vigorously and consistently by identifying key therapeutic gaps in disease management and providing innovative, yet affordable drug therapies. In the same year Panacea Biotec forayed into Pain Management, Organ Transplant & Diabetes Management segments by introducing the unique Non- Steroidal Anti Inflammatory Drug -Nimulid (Nimesulide), Panimun Bioral (Cyclosporin) and Glizid (Gliclazide) respectively. It also came out with it's first public issue on 25.09.1995. Since then it has introduced many more products in its portfolio and earned prestigious international patents for it's technology in drug delivery systems. Today, Nimulid, Panimun Bioral and Glizid are brand leaders in their respective therapeutic categories in India.

With a special focus on biotechnology, Panacea Biotec has been making concerted efforts to improve the repertoire of its vaccines. A host of new vaccines employing genetic engineering and recombinant technology are being developed. The Hepatitis B vaccine- Enivac HB is being manufactured in collaboration with CIGB (Center for Genetic Engineering and Biotechnology), Havana, Cuba- a world leader in biotechnology. Panacea Biotec has recently developed several combination vaccines, some of the leading ones are :

Ecovac (DPT+HepatitisB)
Easy Four (DPT+Hib)
Easy Five (DPT+HepatitisB+Hib)
Few of the promising vaccines under different phases of development are Anthrax Vaccine (recombinant) & Japanese Encephalitis Vaccine. Panacea Biotec has recently formed a joint venture with Chiron Vaccines, a U.S. Based $ 5 billion multinational company, to market vaccines in India. Panacea Biotec has developed thermostable vaccines in collaboration with Cambridge Biostability, a U.K. Based research company. The new "stable liquid" technology makes vaccines stable across a range of temperature thus removing the need for the cold chain. This will enable the children, even in remote areas, to receive economical and safer immunisation from preventable killer diseases.

The collaborations with Chiron Vaccines (U.S.) and Cambridge Biostability (U.K.) provide a significant advantage to Panacea Biotec to speedily progress in the field of biotechnology in coming years.

Panacea Biotec is only one of the few health management companies which is strategically poised to take up new challenges in the post WTO era. Today Panacea Biotec has more than 150 scientists in 3 state of the art R&D centers in the field of Pharmaceuticals, Biopharmaceuticals & Vaccines. The company is now building it's 4th R&D center in Drug Discovery at Mohali near Chandigarh (Punjab). This R&D center is expected to be functional by Q4 in the year 2005.

Panacea Biotec has continued its trend of steady and consistent growth over the years. The total turnover in the financial year 2003-04 has been Rs. 2, 715 Million. The sales of branded formulations in year 2003-04 increased to Rs. 1, 115 million as against Rs. 993 million during the previous year thus recording a growth of 12.28% over the previous year, much higher than the industry growth of 7.3%.

The company has more than 2000 employees on its rolls. Out of this, around 1000 are field sales personnel who promote the products of its five Strategic Business Units (SBU's) - Pro, Grow, Diacar, Critical Care & Bestonhealth to the medical profession. Besides Pain Management, Diabetese Management and Vaccines, the company has significant presence in other therapeutic areas, namely, Organ Transplantation, Osteoporosis, Antibacterial Therapy, Tuberculosis & Gastrointestinal. The company has worldwide patents for many of its products.

Products :
Manufactures and markets branded vaccines, pharmaceutical and biotechnology-based products of international quality. Our product range - Nimulid, Kondro, Mygat, Enivac HB, Ecovac-4, Giro, Airyfen, Zomont, Livoluk, Algiflux Suspension, Algiflux Tablet, Xeed, Myobid, Myser, PanGraf, Efecient, Mycept, Panimun Bioral, Calcom, Osral, Alphadol C, Alphadol, Metlong, Rosimet, Betaglim, Oglo, Glizid.

---

Product Catalog

Anti - Tubercular (Myser)
Myser contain Cycloserine, which is chemically (R)-4-aminoisoxazolidin-3-one; a broad spectrum antibiotic that is produced by a strain of Streptomyces orchidaceous. Myser....

NIMULID-MD-KID TABLETS
Nimulid-MD-KID Tablets contain nimesulide which is chemically 4-Nitro-2-phenoxymethane sulphonanilide. Nimulid-MD-KID Tablets are pale yellow coloured, flavoured, round, ....

Nimulid Suspension (Nimesulide Suspension)
NIMULID SUSPENSION, brand of Nimesulide Suspension is chemically 4-Nitro-2-phenoxymethane sulphonanilide. Nimulid Suspension is yellow coloured, viscous, flavoured suspen....


 View Complete Catalog

---

Contact Info

Mr. Bimalesh Kumar
Manager

PANACEA BIOTEC LTD.

# 39/3143,A,Diwans Road,,
Ernakulam(Kochi) - 682016 (Kerala) India

Phone(s) : +91-484-2372270
Mobile :
Fax : +91-484-2372241


 Visit Website   |    View Product Catalog   |     Send Enquiry

---

---